Population Pharmacokinetics of Vancomycin Under Continuous Renal Replacement Therapy Using a Polymethylmethacrylate Hemofilter

被引:8
作者
Yamazaki, Shingo [1 ]
Tatebe, Mizuki [2 ]
Fujiyoshi, Masachika [2 ]
Hattori, Noriyuki [3 ]
Suzuki, Tatsuya [1 ]
Takatsuka, Hirokazu [1 ]
Uchida, Masashi [1 ,2 ]
Suzuki, Takaaki [1 ,2 ]
Ishii, Itsuko [1 ,2 ]
机构
[1] Chiba Univ Hosp, Div Pharm, 1-8-1 Inohana, Chiba 2608677, Japan
[2] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm, Chiba, Japan
[3] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba, Japan
关键词
sepsis; continuous hemodiafiltration; hemofilter clearance; vancomycin; CONTINUOUS VENOVENOUS HEMOFILTRATION; CYTOKINE-ADSORBING HEMOFILTER; CONTINUOUS HEMODIAFILTRATION; ANTIBIOTICS; CLEARANCE; ADSORPTION;
D O I
10.1097/FTD.0000000000000721
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Although continuous hemodiafiltration (CHDF) is often performed in critically ill patients during sepsis treatment, the pharmacokinetics of vancomycin (VCM) during CHDF with a polymethylmethacrylate hemofilter (PMMA-CHDF) have not been revealed. In this study, the authors aimed to describe the population pharmacokinetics of VCM in critically ill patients undergoing PMMA-CHDF and clarify its hemofilter clearance (CLhemofilter). Methods: This single-center, retrospective study enrolled patients who underwent intravenous VCM therapy during PMMA-CHDF at the intensive care unit of Chiba University Hospital between 2008 and 2016. A population analysis was performed, and CLhemofilter was assessed. Results: Twenty-five patients were enrolled. Median body weight (BW) and Sequential Organ Failure Assessment (SOFA) score were 63 kg and 15, respectively. Mean conditions for CHDF were 107.5 +/- 18.3 mL/min for blood flow rate and 26.3 +/- 6.3 mL/kg/h for effluent flow rate. The mean parameter estimates were distribution volume of the central compartment (V-1), 59.1 L; clearance of the central compartment (CL1), 1.35 L/h; distribution volume of the peripheral compartment (V-2), 56.1 L; and clearance of the peripheral compartment (CL2), 3.65 L/h. BW and SOFA score were significantly associated with V-1 (P < 0.05) and CL1 (P < 0.05), respectively, and were thus selected as covariates in the final model. The estimated dosage of VCM to achieve a target area under the concentration-time curve/minimum inhibitory concentration >= 400 was 27.1 mg/kg for loading and 9.7 mg/kg every 24 hours for maintenance; these dosages were affected by BW and SOFA score. Mean CLhemofilter obtained from 8 patients was 1.35 L/h, which was similar to CL1. Conclusions: The authors clarified the pharmacokinetics and CLhemofilter of VCM in PMMA-CHDF patients. The PK of VCM in patients undergoing CHDF appeared to vary not only with the CHDF setting and BW but also with SOFA score.
引用
收藏
页码:452 / 459
页数:8
相关论文
共 32 条
[1]  
Abe R, 2010, CONTRIB NEPHROL, V166, P54, DOI 10.1159/000314852
[2]   Optimizing the Clinical Use of Vancomycin [J].
Alvarez, Rocio ;
Lopez Cortes, Luis E. ;
Molina, Jose ;
Cisneros, Jose M. ;
Pachon, Jeronimo .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) :2601-2609
[3]   Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients [J].
Boereboom, FTJ ;
Ververs, FFT ;
Blankestijn, PJ ;
Savelkoul, TJF ;
van Dijk, A .
INTENSIVE CARE MEDICINE, 1999, 25 (10) :1100-1104
[4]   Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients [J].
Bugge, JF .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2001, 45 (08) :929-934
[5]   Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients [J].
Chaijamorn, Weerachai ;
Jitsurong, Arnurai ;
Wiwattanawongsa, Kamonthip ;
Wanakamanee, Usanee ;
Dandecha, Phongsak .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (02) :152-156
[6]   Principles of Antibacterial Dosing in Continuous Renal Replacement Therapy [J].
Choi, Gordon ;
Gomersall, Charles D. ;
Tian, Qi ;
Joynt, Gavin M. ;
Li, Alexander M. M. Y. ;
Lipman, Jeffrey .
BLOOD PURIFICATION, 2010, 30 (03) :195-212
[7]   Relationship between hemoglobin levels and vancomycin clearance in patients with sepsis [J].
Chuma, Masayuki ;
Makishima, Makoto ;
Imai, Toru ;
Tochikura, Naohiro ;
Suzuki, Shinichiro ;
Kuwana, Tsukasa ;
Sawada, Nami ;
Iwabuchi, So ;
Sekimoto, Masao ;
Nakayama, Takahiro ;
Sakaue, Takako ;
Kikuchi, Norikazu ;
Yoshida, Yoshikazu ;
Kinoshita, Kosaku .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (07) :929-937
[8]   Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis [J].
Chuma, Masayuki ;
Makishima, Makoto ;
Imai, Toru ;
Tochikura, Naohiro ;
Sakaue, Takako ;
Kikuchi, Norikazu ;
Kinoshita, Kosaku ;
Kaburaki, Morio ;
Yoshida, Yoshikazu .
CLINICAL THERAPEUTICS, 2016, 38 (12) :2598-2609
[9]   Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model-based meta-analytic approach [J].
Claisse, Guillaume ;
Zufferey, Paul J. ;
Trone, Jane C. ;
Maillard, Nicolas ;
Delavenne, Xavier ;
Laporte, Silvy ;
Ollier, Edouard .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (06) :1215-1226
[10]   Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration [J].
DelDot, ME ;
Lipman, J ;
Tett, SE .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (03) :259-268